Literature DB >> 27105081

The Incidence of Parkinson's Disease: A Systematic Review and Meta-Analysis.

Lauren Hirsch1, Nathalie Jette, Alexandra Frolkis, Thomas Steeves, Tamara Pringsheim.   

Abstract

BACKGROUND: Parkinson's disease (PD) is a common neurodegenerative disorder. Epidemiological studies on the incidence of PD are important to better understand the risk factors for PD and determine the condition's natural history.
OBJECTIVE: This systematic review and meta-analysis examine the incidence of PD and its variation by age and gender.
METHODS: We searched MEDLINE and EMBASE for epidemiologic studies of PD from 2001 to 2014, as a previously published systematic review included studies published until 2001. Data were analyzed separately for age group and gender, and meta-regression was used to determine whether a significant difference was present between groups.
RESULTS: Twenty-seven studies were included in the analysis. Meta-analysis of international studies showed rising incidence with age in both men and women. Significant heterogeneity was observed in the 80+ group, which may be explained by methodological differences between studies. While males had a higher incidence of PD in all age groups, this difference was only statistically significant for those in the age range 60-69 and 70-79 (p < 0.05).
CONCLUSION: PD incidence generally increases with age, although it may stabilize in those who are 80+.
© 2016 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2016        PMID: 27105081     DOI: 10.1159/000445751

Source DB:  PubMed          Journal:  Neuroepidemiology        ISSN: 0251-5350            Impact factor:   3.282


  126 in total

1.  Androgen deprivation therapy and the risk of parkinsonism in men with prostate cancer.

Authors:  James W S Young; Rinku Sutradhar; Jagadish Rangrej; Connie Marras; Neil Fleshner; Shabbir M H Alibhai
Journal:  World J Urol       Date:  2017-02-15       Impact factor: 4.226

2.  Sex on the brain: Unraveling the differences between women and men in neurodegenerative disease.

Authors:  Mike May
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

3.  GLP-1 receptor agonists for Parkinson's disease.

Authors:  Caroline A Mulvaney; Gonçalo S Duarte; Joel Handley; David Jw Evans; Suresh Menon; Richard Wyse; Hedley Ca Emsley
Journal:  Cochrane Database Syst Rev       Date:  2020-07-23

4.  Basal and Evoked Neurotransmitter Levels in Parkin, DJ-1, PINK1 and LRRK2 Knockout Rat Striatum.

Authors:  Rose B Creed; Liliana Menalled; Bradford Casey; Kuldip D Dave; Holden B Janssens; Isaac Veinbergs; Marieke van der Hart; Arash Rassoulpour; Matthew S Goldberg
Journal:  Neuroscience       Date:  2019-04-25       Impact factor: 3.590

Review 5.  Management of Hypertension and Blood Pressure Dysregulation in Patients with Parkinson's Disease-a Systematic Review.

Authors:  Vasiliki Katsi; Ilias Papakonstantinou; Eirini Solomou; Alexios S Antonopoulos; Charalambos Vlachopoulos; Konstantinos Tsioufis
Journal:  Curr Hypertens Rep       Date:  2021-05-07       Impact factor: 5.369

Review 6.  [Parkinson's disease in the elderly].

Authors:  Rüdiger Lange; Frank Erbguth
Journal:  Z Gerontol Geriatr       Date:  2017-07-19       Impact factor: 1.281

Review 7.  Sex Differences in the Gut-Brain Axis: Implications for Mental Health.

Authors:  Calliope Holingue; Alexa Curhan Budavari; Katrina M Rodriguez; Corina R Zisman; Grace Windheim; M Daniele Fallin
Journal:  Curr Psychiatry Rep       Date:  2020-11-20       Impact factor: 5.285

Review 8.  Tyrosine hydroxylase (TH), its cofactor tetrahydrobiopterin (BH4), other catecholamine-related enzymes, and their human genes in relation to the drug and gene therapies of Parkinson's disease (PD): historical overview and future prospects.

Authors:  Toshiharu Nagatsu; Ikuko Nagatsu
Journal:  J Neural Transm (Vienna)       Date:  2016-08-04       Impact factor: 3.575

9.  Qualitative analysis of Parkinson's disease information on social media: the case of YouTube™.

Authors:  Ibrahim Saleh Al-Busaidi; Tim J Anderson; Yassar Alamri
Journal:  EPMA J       Date:  2017-08-23       Impact factor: 6.543

10.  Pharmacological and chemogenetic orexin/hypocretin intervention ameliorates Hipp-dependent memory impairment in the A53T mice model of Parkinson's disease.

Authors:  Milos Stanojlovic; Jean Pierre Pallais; Michael K Lee; Catherine M Kotz
Journal:  Mol Brain       Date:  2019-10-30       Impact factor: 4.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.